NZ197026A - N-diaminomethylene-(2,5-dihydro-1h pyrrol-1-yl) acetamides in antidiarrhoeal compositions - Google Patents
N-diaminomethylene-(2,5-dihydro-1h pyrrol-1-yl) acetamides in antidiarrhoeal compositionsInfo
- Publication number
- NZ197026A NZ197026A NZ197026A NZ19702681A NZ197026A NZ 197026 A NZ197026 A NZ 197026A NZ 197026 A NZ197026 A NZ 197026A NZ 19702681 A NZ19702681 A NZ 19702681A NZ 197026 A NZ197026 A NZ 197026A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutically acceptable
- uas
- guanidine
- acid addition
- dihydro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8017377 | 1980-05-27 | ||
| GB8104410 | 1981-02-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ197026A true NZ197026A (en) | 1984-05-31 |
Family
ID=26275656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ197026A NZ197026A (en) | 1980-05-27 | 1981-05-07 | N-diaminomethylene-(2,5-dihydro-1h pyrrol-1-yl) acetamides in antidiarrhoeal compositions |
Country Status (18)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4714707A (en) * | 1984-01-13 | 1987-12-22 | Rorer Pharmaceutical Corporation | Aryl substituted heterocycles for treating gastrointestinal motility dysfunction |
| GB8525013D0 (en) * | 1985-10-10 | 1985-11-13 | Wyeth John & Brother Ltd | Antidiarrhoel agents |
| DK153442C (da) * | 1985-10-14 | 1988-12-19 | Poul Bachmann | Middel, baseret paa pektinholdigt materiale, til behandling og forebyggelse af diarre hos mennesker og dyr |
| GB8806224D0 (en) * | 1988-03-16 | 1988-04-13 | Johnson Matthey Plc | Platinum chemotherapeutic product |
| US20050191403A1 (en) * | 2002-05-23 | 2005-09-01 | Glutagen Pty Ltd | Palliative treatment for gluten intolerance |
| US7976872B2 (en) * | 2006-07-24 | 2011-07-12 | L. Perrigo Company | Method for distributing a pharmaceutically active compound in an excipient |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1530675A (en) * | 1976-06-05 | 1978-11-01 | Wyeth John & Brother Ltd | Guanidine derivatives |
-
1981
- 1981-05-01 CA CA000376666A patent/CA1158558A/en not_active Expired
- 1981-05-06 IL IL62809A patent/IL62809A/xx unknown
- 1981-05-06 AU AU70203/81A patent/AU539121B2/en not_active Ceased
- 1981-05-07 NZ NZ197026A patent/NZ197026A/en unknown
- 1981-05-08 GR GR64893A patent/GR74922B/el unknown
- 1981-05-11 US US06/262,148 patent/US4443467A/en not_active Expired - Fee Related
- 1981-05-11 ZW ZW113/81A patent/ZW11381A1/xx unknown
- 1981-05-15 PH PH25641A patent/PH16855A/en unknown
- 1981-05-19 EP EP81302211A patent/EP0040947B1/en not_active Expired
- 1981-05-19 DE DE8181302211T patent/DE3175672D1/de not_active Expired
- 1981-05-19 GB GB8115356A patent/GB2080107B/en not_active Expired
- 1981-05-20 IT IT21847/81A patent/IT1136619B/it active
- 1981-05-22 MX MX819461U patent/MX6962E/es unknown
- 1981-05-25 DK DK228381A patent/DK228381A/da unknown
- 1981-05-25 FI FI811601A patent/FI811601A7/fi not_active Application Discontinuation
- 1981-05-26 PT PT73087A patent/PT73087B/pt unknown
- 1981-05-26 ES ES502487A patent/ES8302647A1/es not_active Expired
-
1982
- 1982-06-16 ES ES514335A patent/ES514335A0/es active Granted
- 1982-06-16 ES ES514336A patent/ES514336A0/es active Granted
- 1982-07-30 PH PH27647A patent/PH17361A/en unknown
-
1987
- 1987-12-30 MY MY598/87A patent/MY8700598A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH16855A (en) | 1984-03-19 |
| CA1158558A (en) | 1983-12-13 |
| EP0040947B1 (en) | 1986-12-03 |
| MX6962E (es) | 1987-01-08 |
| MY8700598A (en) | 1987-12-31 |
| ES8305316A1 (es) | 1983-04-16 |
| EP0040947A1 (en) | 1981-12-02 |
| ES8305317A1 (es) | 1983-04-16 |
| GB2080107A (en) | 1982-02-03 |
| IL62809A (en) | 1984-03-30 |
| IT1136619B (it) | 1986-09-03 |
| ZW11381A1 (en) | 1982-11-17 |
| FI811601L (fi) | 1981-11-28 |
| PT73087A (en) | 1981-06-01 |
| AU539121B2 (en) | 1984-09-13 |
| ES502487A0 (es) | 1983-02-01 |
| IT8121847A0 (it) | 1981-05-20 |
| PH17361A (en) | 1984-08-01 |
| FI811601A7 (fi) | 1981-11-28 |
| US4443467A (en) | 1984-04-17 |
| IL62809A0 (en) | 1981-07-31 |
| DK228381A (da) | 1981-11-28 |
| GR74922B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-07-12 |
| ES514336A0 (es) | 1983-04-16 |
| AU7020381A (en) | 1981-12-03 |
| ES8302647A1 (es) | 1983-02-01 |
| ES514335A0 (es) | 1983-04-16 |
| PT73087B (en) | 1985-01-08 |
| GB2080107B (en) | 1986-02-26 |
| DE3175672D1 (en) | 1987-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6455537B1 (en) | Methods for treating opiate intolerance | |
| CA1212323A (en) | Method for improving gastrointestinal motility | |
| US4593034A (en) | 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides | |
| EA000976B1 (ru) | Композиция для снятия боли и способ снятия боли | |
| EP0222533A1 (en) | Cis-N-[(2-aminocycloaliphatic)benzene acetamide and -benzamide anticonvulsants | |
| NZ197026A (en) | N-diaminomethylene-(2,5-dihydro-1h pyrrol-1-yl) acetamides in antidiarrhoeal compositions | |
| IE81142B1 (en) | Divalent metal salts of indomethacin | |
| EP0531228B1 (en) | Thiourea derivatives, antimicrobial agent and antiulcer agent containing the same | |
| SU927111A3 (ru) | Способ получени оксимэфиров или их солей | |
| JPH05132430A (ja) | 薬物従属症及び禁断症状の治療に関するグリシン／ｎｍｄａレセプターリガンドの用法 | |
| EA000531B1 (ru) | Активное вещество при производстве фармацевтического препарата для лечения травматического повреждения головного мозга | |
| US4312879A (en) | Clonidine and lofexidine as antidiarrheal agents | |
| GB2181347A (en) | Antidiarrhoeal agents containing guanidine derivatives | |
| US4259346A (en) | Bradycardiac pharmaceutical compositions and method of use | |
| IE51716B1 (en) | ANTIDIARRHOEAL AGENTS. IE | |
| SK17332001A3 (sk) | Polymorfné formy kryštalického azabicyklo [2.2.2] oktán-3-amín-citrátu a farmaceutické kompozície ich obsahujúce | |
| SK11695A3 (en) | Use of 3-benzoyl-3,7-diazobicyclo£3,3,1| nonane compounds as antiarhytmic effective medicament and method of its production | |
| BG61242B2 (bg) | Твърд фармацевтичен състав за орална употреба на база дапипразол | |
| EP0523013B1 (en) | Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases | |
| US3743732A (en) | Process for suppressing the tremor of parkinson's syndrome | |
| US4334071A (en) | 17-Cyclobutylmethyl-3-hydroxy-8β-methyl-6-methylene-morphinane methanesulfonate | |
| US3849578A (en) | Anti-inflammatory treatment | |
| EP0171912B1 (en) | Pyrrolizidine compounds, methods for their production, and their uses | |
| US6303608B1 (en) | 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use | |
| US3432490A (en) | 2-(beta-hexamethylene imino ethyl) cyclohexanone - 2 - carboxylic acid benzyl ester and salts thereof |